(-)-Borneol

(-)-borneol is a lipid of Prenol Lipids (PR) class. The involved functions are known as Protein-Protein Interaction.

Cross Reference

Introduction

To understand associated biological information of (-)-Borneol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (-)-Borneol?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (-)-Borneol

MeSH term MeSH ID Detail
Ischemic Attack, Transient D002546 42 associated lipids
Colitis D003092 69 associated lipids
Brain Ischemia D002545 89 associated lipids
Hypertension D006973 115 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 | Total 16

PubChem Associated disorders and diseases

What pathways are associated with (-)-Borneol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (-)-Borneol?

There are no associated biomedical information in the current reference collection.

What functions are associated with (-)-Borneol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (-)-Borneol?

There are no associated biomedical information in the current reference collection.

What genes are associated with (-)-Borneol?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with (-)-Borneol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (-)-Borneol

Download all related citations
Per page 10 20 50 100 | Total 236
Authors Title Published Journal PubMed Link
Xu X et al. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. 2016 Eur J Pharm Sci pmid:26965003
Li WR et al. Pharmacokinetics of natural borneol after oral administration in mice brain and its effect on excitation ratio. 2012 Eur J Drug Metab Pharmacokinet pmid:21948240
Wu C et al. Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice. 2014 Eur J Drug Metab Pharmacokinet pmid:23673491
Zhang R et al. Effect of borneol on cytochrome P450 3A enzyme and midazolam pharmacokinetics in rats. 2013 Eur J Drug Metab Pharmacokinet pmid:23589122
Bruder S et al. Use of fuzzy logic models for prediction of taste and odor compounds in algal bloom-affected inland water bodies. 2014 Environ Monit Assess pmid:24242080
Kim H et al. Identification and characterization of potent CYP2B6 inhibitors in Woohwangcheongsimwon suspension, an herbal preparation used in the treatment and prevention of apoplexy in Korea and China. 2008 Drug Metab. Dispos. pmid:18332082
Surendradoss J et al. Evaluation of in situ generated valproyl 1-O-β-acyl glucuronide in valproic acid toxicity in sandwich-cultured rat hepatocytes. 2014 Drug Metab. Dispos. pmid:25147275
Grillo MP et al. Stereoselective flunoxaprofen-S-acyl-glutathione thioester formation mediated by acyl-CoA formation in rat hepatocytes. 2010 Drug Metab. Dispos. pmid:19786506
Koga T et al. Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes. 2011 Drug Metab. Dispos. pmid:20926620
Yi T et al. Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. 2017 Drug Deliv pmid:28165806